phase readout
saveNCT04375228: Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
ACTIVE_NOT_RECRUITINGupdated 28m ago
community read0 votes
Sponsor: Columbia University. Phase: PHASE2. Conditions: Immune-related Adverse Events, Advanced Solid Tumor
view source ↗
comments(0)
5-min edit window · permanent after that